SCHEMBL6405892

SCHEMBL6405892

CCc1ccc(OCc2nnc(S)n2Cc2ccccc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.60
ADAMTS5 Q9UNA0 2/20 0.50
LMNA P02545 4/20 0.47
RECQL P46063 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NPSR1 Q6W5P4 3/20 0.46
GAA P10253 2/20 0.46
TSHR P16473 1/20 0.46
ALDH1A1 P00352 4/20 0.45
HPGD P15428 2/20 0.45
SIRT2 Q8IXJ6 1/20 0.44
TP53 P04637 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
POLB P06746 3/20 0.43
CYP1A2 P05177 1/20 0.43
HTT P42858 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15801095 0.80 KDM4E (0.45) MAPTLMNARECQLNPSR1TSHR
SCHEMBL10012011 0.79 TSHR (0.52) MAPTLMNAL3MBTL1TSHRALDH1A1
SCHEMBL6404731 0.78 ALDH1A1 (0.59) LMNAL3MBTL1NPSR1GAATSHR
SCHEMBL6404334 0.77 GAA (0.71) MAPTLMNARECQLL3MBTL1NPSR1
SCHEMBL10480370 0.75 CYP19A1 (0.45) MAPTLMNANPSR1TSHRALDH1A1
SCHEMBL10480359 0.73 ALDH1A1 (0.51) MAPTLMNANPSR1GAATSHR
SCHEMBL10012854 0.73 SMN1; SMN2 (0.52) MAPTADAMTS5LMNANPSR1TSHR
SCHEMBL6405035 0.72 MAPT (0.53) MAPTLMNATSHRALDH1A1TP53
SCHEMBL464352 0.72 RXRA (0.66) MAPTLMNAL3MBTL1NPSR1GAA
SCHEMBL10480361 0.71 NPC1 (0.54) ALDH1A1NPC1POLBCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT MAPT 2111/4885ADAMTS5 1031/4885LMNA 4116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.